The regulation of PTX3 expression is through cisplatin-induced ROS production in head and neck squamous cell carcinoma
碩士 === 國立成功大學 === 生物科技與產業科學系 === 106 === Head and neck squamous cell carcinoma (HNSCC) is sixth common cancer in the world. HNSCC develops from many tissues including lip, parotid glands, nasal cavity, paranasal sinuses, pharynx, larynx or oral cavity. Cisplatin is a well-known chemotherapeutic drug...
Main Authors: | Yi-ZheWu, 吳宜哲 |
---|---|
Other Authors: | Ben-Kuen Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/tvdq33 |
Similar Items
-
The role of PTX3 in anti-cancer drug-induced head and neck squamous cell carcinomas dormancy and metastasis
by: Zhao-LingZheng, et al.
Published: (2019) -
Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy
by: Beatriz I. Fernandez-Gil, et al.
Published: (2019-01-01) -
Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma.
by: Chi T Viet, et al.
Published: (2014-01-01) -
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
by: Zejia Yang, et al.
Published: (2019-05-01) -
Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
by: Shutong Liu, et al.
Published: (2017-09-01)